• Technology
  • Patients
  • Investors
  • About Us
  • News
Clinical Milestone Achieved: Positive Early Human Trial Results for Hypersound RF Pain Management Device

Clinical Milestone Achieved: Positive Early Human Trial Results for Hypersound RF Pain Management Device

by roumianad | Jan 25, 2026 | News

Hypersound Medical, a medical technology innovator developing non-invasive, ultrasound-based therapies for chronic and acute pain, announced positive responses from the first human participants in its early-stage clinical trial evaluating the company’s novel RF-based...
Clinical Milestone Achieved: Positive Early Human Trial Results for Hypersound RF Pain Management Device

Hypersound Medical Placed on the National Science Foundation’s Fast-Track program

by roumianad | Aug 10, 2025 | News

Hypersound Medical, a medical technology innovator developing non-invasive, ultrasound-based therapies for chronic and acute pain, announced it has been placed on the National Science Foundation (NSF) Fast-Track program, accelerating the company’s path toward Medicare...
Clinical Milestone Achieved: Positive Early Human Trial Results for Hypersound RF Pain Management Device

Hypersound Medical Featured in IEEE Pulse for Breakthrough Non-Invasive Chronic Pain Therapy

by roumianad | Jun 20, 2025 | News

Hypersound Medical, a pioneer in non-invasive neuromodulation, is proud to announce that its innovative radio-frequency–based pain therapy has been featured in the prestigious IEEE Pulse magazine. The article, titled “Zap the Pain, Skip the Pills: Noninvasive Chronic...
Clinical Milestone Achieved: Positive Early Human Trial Results for Hypersound RF Pain Management Device

Hypersound Medical Selected Among the 25 Semifinalists for the 2024 Arizona Innovation Challenge

by roumianad | Oct 10, 2024 | News

Hypersound Medical, a company specializing in innovative medical devices, announced that it is one of the 25 semifinalists selected for the 2024 Arizona Innovation Challenge. The Arizona Innovation Challenge (AIC) is one of the largest business plan competitions in...
Clinical Milestone Achieved: Positive Early Human Trial Results for Hypersound RF Pain Management Device

Hypersound Medical Receives Funding through Arizona’s Small Business Administration’s Federal and State Technology Partnership Program

by roumianad | Aug 16, 2023 | News

Hypersound Medical, a company specializing in innovative medical devices, announced that it was awarded a grant through Arizona’s Small Business Administration’s Federal and State Technology (FAST) Partnership Program.  The FAST program prepares entrepreneurs to...
Clinical Milestone Achieved: Positive Early Human Trial Results for Hypersound RF Pain Management Device

Hypersound Medical Receives the Arizona New Economy Initiative Award for Science and Technology

by roumianad | Jun 1, 2023 | News

Hypersound Medical, a company specializing in innovative medical devices, announced that it was awarded the Arizona New Economy Initiative (NEI) Award.  The award was given to Dr. Jitendran Muthuswamy, Associate Professor at the School of Biological and Health Systems...
« Older Entries

Recent Posts

  • Clinical Milestone Achieved: Positive Early Human Trial Results for Hypersound RF Pain Management Device
  • Hypersound Medical Placed on the National Science Foundation’s Fast-Track program
  • Hypersound Medical Featured in IEEE Pulse for Breakthrough Non-Invasive Chronic Pain Therapy
  • Hypersound Medical Selected Among the 25 Semifinalists for the 2024 Arizona Innovation Challenge
  • Hypersound Medical Receives Funding through Arizona’s Small Business Administration’s Federal and State Technology Partnership Program

Recent Comments

No comments to show.

Leading the way in effective, non-invasive, affordable pain management technology.

Technology

Patients

Investors

About Us

Company News

Contacts

Privacy Policy

Copyright © 2026Hypersound Medical. All Rights Reserved.

CAUTION: Investigational Device. Limited by Federal (or United States) law to investigational use. The Hypersound device is not intended to diagnose, treat, cure, or prevent any disease. It is currently in the process of being evaluated by FDA.